Quick Answer
NextCure, Inc. reported Shares Outstanding of 3.51 million shares for fiscal year 2025.
NextCure, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 3.51M | +50.2% |
| 2024 | 2.33M | -91.6% |
| 2023 | 27.90M | +0.5% |
| 2022 | 27.77M | +0.3% |
| 2021 | 27.68M | +0.4% |
| 2020 | 27.57M | +0.3% |
| 2019 | 27.50M | +76.7% |
| 2019 | 15.56M | +1031.8% |
| 2018 | 1.37M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 2.68M | -90.4% | +14.5% |
| June 30, 2025 | 2.34M | -91.6% | -91.7% |
| March 31, 2025 | 28.01M | +0.4% | +1100.0% |
| December 31, 2024 | 2.33M | -91.6% | -91.7% |
| September 30, 2024 | 27.98M | +0.5% | +0.0% |
| June 30, 2024 | 27.98M | +0.5% | +0.3% |
| March 31, 2024 | 27.90M | +0.5% | +0.0% |
| December 31, 2023 | 27.90M | +0.5% | +0.2% |
- NextCure, Inc. showed an increase of +50.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, NextCure, Inc.’s shares outstanding has grown by 155.0% (from 1.37 million shares to 3.51 million shares).
- The most recent figure is from NextCure, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: